The participant is still hospitalized. The CT scan results will not be available until tomorrow. The gastroenterology consult is scheduled for Wednesday. The investigator marked causality as "possibly related" on the initial report but noted that additional diagnostic information could change that assessment. The study drug has been held, but the team has not yet decided whether the hold will become permanent discontinuation.

The initial SAE report captured a snapshot. But the event is a story, and stories do not end with the first paragraph. The participant's clinical course will evolve. New information will arrive. Diagnoses will be confirmed or revised. Treatments will be administered, and the participant will either recover or will not. Every material development in that story requires a follow-up report -- an update that adds to the record, revises what has changed, and moves the case closer to its conclusion.

This is the part of SAE reporting that receives, in my view, far less attention than it deserves. The 24-hour initial report gets all the training emphasis -- it has a deadline, it has urgency, it feels like a crisis. But the follow-up cycle is where the real clinical story is told. And it is the follow-up reports, not the initial snapshot, that regulators and safety committees ultimately rely on when evaluating the event.

The participant is still hospitalized. The CT scan results will not be available until tomorrow. The gastroenterology consult is scheduled for Wednesday. The investigator marked causality as "possibly related" on the initial report but noted that additional diagnostic information could change that assessment. The study drug has been held, but the team has not yet decided whether the hold will become permanent discontinuation.

The initial SAE report captured a snapshot. But the event is a story, and stories do not end with the first paragraph. The participant's clinical course will evolve. New information will arrive. Diagnoses will be confirmed or revised. Treatments will be administered, and the participant will either recover or will not. Every material development in that story requires a follow-up report -- an update that adds to the record, revises what has changed, and moves the case closer to its conclusion.

This is the part of SAE reporting that receives, in my view, far less attention than it deserves. The 24-hour initial report gets all the training emphasis -- it has a deadline, it has urgency, it feels like a crisis. But the follow-up cycle is where the real clinical story is told. And it is the follow-up reports, not the initial snapshot, that regulators and safety committees ultimately rely on when evaluating the event.